Use of Riboflavin in the Treatment of Hypertension.

The invention provides the use of riboflavin in the manufacture of a medicament for the treatment or prophylaxis of elevated blood pressure in a subject homozygous or heterozygous for the MTHFR C677T polymorphism. The invention also provides a pharmaceutical product for the treatment or prophylaxis of elevated blood pressure in a subject homozygous or heterozygous for the MTHFR C677T polymorphism, comprising a pharmaceutically effective amount of an anti-hypertensive agent and riboflavin, and the invention further provides a method of treatment of such a subject comprising the administration of riboflavin.

Patents:
MX 2,009,009,020

Inventor(s): WARD MARY [GB]; MCNULTY HELENE; HORIGAN GERALDINE; STRAIN SEAN; SCOTT JOHN; PURVIS JOHN

Type of Offer: Sale



« More Pharmaceutical Patents
« More Medical Patents

---